|
|
|
|
ISSN: 1040-8401 Print
|
|
|
|
| |
You can order a single issue or an individual article, as well as view the table of contents or article abstract by clicking on the volume number, then the issue number in the right sidebar.
|
|
|
|
|
|
Institutional price: $942.00
|
|
Online subscription
|
|
Year 2001, Volume 21 / Issue 1-3
|
Issue price - $396.00
|
|
Pages: 310
TABLE OF CONTENTS:
|
Article |
|
On the Initial Trigger of Myasthenia Gravis and Suppression of the Disease by Antibodies Against the MHC Peptide Region Involved in the Presentation of a Pathogenic T-Cell Epitope
Zouhair Atassi, Minako Oshima, Philip Deitiker
pages 27
|
|
A Nondeletional Mechanism for Central T-Cell Tolerance
Robert L. Rubin, Anke Kretz-Rommel
pages 12
|
|
T-Cell Vaccination in Multiple Sclerosis: Immunoregulatory Mechanism and Prospects for Therapy
Jingwu Zhang
pages 15
|
|
T-Cell Receptor-Derived Peptides in Immunoregulation and Therapy of Retrovirally Induced Immunosuppression
John J. Marchalonis, Ian F. Robey, Allen B. Edmundson, R. Tomas Sepulveda, Ronald R. Watson
pages 18
|
|
Induction and Direction of Immune Responses by Vaccine Adjuvants
Virgil E. J. C. Schijns
pages 11
|
|
The Basis of Immunogenicity of Endocrine Allografts
Mark R. Nicolls, Marilyne Coulombe, Ronald G. Gill
pages 15
|
|
The Potential of CpG Oligodeoxynucleotides as Mucosal Adjuvants
Risini D. Weeratna, Paul J. Payette, Heather L. Davis
pages 18
|
|
Peripheral Nonresponsiveness to Orally Administered Soluble Protein Antigens
Cathryn Nagler-Anderson, Hai Ning Shi
pages 11
|
|
Dendritic Cells in Cancer Immunotherapy
Matthias Gunzer, Stephan Grabbe
pages 13
|
|
Therapeutic Potential of Leukemia-Derived Dendritic Cells: Preclinical and Clinical Progress
David F. Claxton, John McMannis, Richard Champlin, A. Choudhury
pages 9
|
|
Diverse Functional Activity of CD83+ Monocyte-Derived Dendritic Cells and the Implications for Cancer Vaccines
Brian J. Czerniecki, Peter A. Cohen, Mark Faries, Shuwen Xu, James G. Roros, Isabelle Bedrosian
pages 22
|
|
CD14+ Monocytes as Dendritic Cell Precursors: Diverse Maturation-Inducing Pathways Lead to Common Activation of NF-kB/RelB
Gary K. Koski, Lyudmila A. Lyakh, Peter A. Cohen, Nancy R. Rice
pages 12
|
|
Nonmyeloablative Blood Stem Cell Transplantation as Adoptive Allogeneic Immunotherapy for Metastatic Renal Cell Carcinoma
Richard W. Childs
pages 14
|
|
The Identification and Development of Specific Monoclonal Antibodies to Squamous Cell Carcinoma
Myron Arlen, Al Tsang, Joseph Scherrer, Joyce Wolf, Olga Saric
pages 10
|
|
T-Cell Adoptive Therapy of Tumors: Mechanisms of Improved Therapeutic Performance
Liaomin Peng, Peter A. Cohen, Jorgen Kjaergaard, Gregory E. Plautz, James H. Finke, Gary K. Koski, Brian J. Czerniecki, Suyu Shu
pages 34
|
|
A Unique Folate Hydrolase, Prostate-Specific Membrane Antigen (PSMA): A Target For Immunotherapy?
Jason Tasch, Mike Gong, Michel Sadelain, Warren D. W. Heston
pages 13
|
|
Clinical Translation of Peptide-Based Vaccine Trials: The HER-2/neu Model
Mary L. Disis, Keith L. Knutson, Douglas G. McNeel, Donna Davis, Kathy Schiffman
pages 11
|
|
Targeting the ATF-1/CREB Transcription Factors by Single Chain Fv Fragment in Human Melanoma: Potential Modality for Cancer Therapy
Didier Jean, Menashe Bar-Eli
pages 12
|
|
Quantitating Therapeutically Relevant T-Cell Responses to Cancer Vaccines
Amy C. Hobeika, Timothy M. Clay, Paul J. Mosca, H. Kim Lyerly, Michael A. Morse
pages 11
|
|
Overexpressed Cell Surface Interleukin-4 Receptor Molecules Can Be Successfully Targeted for Antitumor Cytotoxin Therapy
Koji Kawakami, Mariko Kawakami, Raj K. Puri
pages 12
|
|
|
Volume 30, 2010 Volume 29, 2009 Volume 28, 2008 Volume 27, 2007 Volume 26, 2006 Volume 25, 2005 Volume 24, 2004 Volume 23, 2003 Volume 22, 2002 Volume 21, 2001 Volume 20, 2000 Volume 19, 1999
|
